文献速递胸部外周血管介入CT

非增强双能量CT碘定量用于球囊肺动脉成形术后肺损伤特征分析

Non-contrast dual-energy CT iodine quantification for lung injury characterization after balloon pulmonary angioplasty.
PubMed 文献 · Eur J Radiol · 2025-04-21

本研究回顾性纳入2019年1月至2023年4月因慢性血栓栓塞性肺动脉高压行球囊肺动脉成形术后接受非增强双能量CT检查的患者,比较咯血组与非咯血组新发肺损伤的碘浓度。咯血组肺损伤中位碘浓度显著高于非咯血组(3.4 mg/mL vs 0.6 mg/mL,p<0.001),CT形态学特征与咯血无显著相关。非增强双能量CT碘浓度可能作为术后肺出血的影像标志物。

要点

  • 球囊肺动脉成形术后新发肺损伤中,咯血患者碘浓度中位3.4 mg/mL,显著高于非咯血患者的0.6 mg/mL。
  • 咯血组肺损伤碘浓度显著高于正常肺实质不同区域(p<0.001),非咯血组肺损伤与正常肺实质间无显著差异。
  • 病灶形态、密度、ROI面积及晕征与咯血无显著相关,碘浓度是区分肺出血与再灌注肺水肿的潜在指标。

核心结论

  • 非增强双能量CT可识别球囊肺动脉成形术后咯血患者与非咯血患者肺损伤之间的碘浓度差异,碘浓度升高可能作为术后肺出血的影像标志物。

研究设计与样本

  • 回顾性研究,纳入2019年1月至2023年4月因咯血或临床恶化在球囊肺动脉成形术后接受非增强双能量CT检查的患者,共13例患者、32处新发肺损伤,按是否发生球囊肺动脉成形术相关咯血分组。

关键影像表现/征象

  • 新发肺损伤表现为新出现的肺部病灶,记录病灶形态、影像模式、绝对密度、ROI大小及晕征。
  • 咯血组肺损伤碘浓度中位3.4 mg/mL,非咯血组中位0.6 mg/mL。
  • 咯血组肺损伤碘浓度显著高于同侧正常肺实质、同叶及对侧肺(p<0.001)。
  • 非咯血组肺损伤与正常肺实质各部位碘浓度无显著差异(p=0.167、p=0.351、p=0.246)。
  • 绝对密度(p=0.767)、病灶形态(p=0.610)、影像表现(p=0.530)、ROI面积(p=0.452)及晕征(p=0.810)与咯血无显著相关。

诊断标准与关键数值

  • 以是否发生球囊肺动脉成形术相关咯血为分组标准,比较新发肺损伤的碘浓度。
  • 咯血组肺损伤碘浓度中位3.4 mg/mL vs 非咯血组0.6 mg/mL,p<0.001。
  • 非咯血组肺损伤与正常肺实质碘浓度比较无显著差异(p=0.167、p=0.351、p=0.246)。

临床应用与阅片要点

  • 作者认为,非增强双能量CT碘浓度升高可能作为球囊肺动脉成形术后肺出血的影像标志物。
  • 作者指出,该探索性研究显示非增强双能量CT有潜力区分慢性血栓栓塞性肺动脉高压患者球囊肺动脉成形术后肺损伤中的肺出血与再灌注肺水肿。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

UNLABELLED: ObjectivesThis study aimed to identify differences in iodine concentrations in new-onset pulmonary injuries and normal lung parenchyma after balloon pulmonary angioplasty (BPA) for chronic thromboembolic pulmonary hypertension (CTEPH) using non-contrast dual-energy CT (NC-DECT) between patients with pulmonary hemorrhage and reperfusion pulmonary edema.

METHODS: Patients undergoing NC-DECT after BPA between January 2019 and April 2023 due to hemoptysis or clinical worsening were retrospectively evaluated for inclusion. Patients were divided based on the presence or absence of BPA-related hemoptysis. Intralesional iodine concentrations were measured in new-onset lung injuries, adjacent normal parenchyma, same lobe, and contralateral lung. CT morphological features, including lesion shape, imaging pattern, absolute density, and ROI size, were recorded. Statistical comparisons were performed using Mann-Whitney U, Friedman, and Wilcoxon signed-rank tests.

RESULTS: Thirteen patients with 32 new-onset post-BPA lung injuries were included. Median iodine concentration in lung injuries was significantly higher in patients with hemoptysis than those without (3.4 mg/mL versus 0.6 mg/mL; p < 0.001). In the hemoptysis group, iodine concentration in lung injuries was significantly higher compared with the different locations of normal lung parenchyma (p < 0.001). In the non-hemoptysis group, no significant differences in iodine concentration were observed between lung injuries and normal parenchyma (p = 0.167; p = 0.351; p = 0.246). Absolute density (p = 0.767), lesion shape (p = 0.610), imaging appearance (p = 0.530), ROI area (p = 0.452), and halo sign (p = 0.810) showed no significant correlation with hemoptysis.

CONCLUSION: NC-DECT identifies iodine concentration differences in lung injuries between patients with and without hemoptysis after BPA. Elevated iodine concentrations may serve as an imaging marker for post-procedural pulmonary hemorrhage.

CRITICAL RELEVANCE STATEMENT: This exploratory study demonstrates the potential of NC-DECT in distinguishing between pulmonary hemorrhage and reperfusion pulmonary edema in lung injuries after BPA in patients with CTEPH. The ability to quantify iodine concentrations in lung lesions offers a novel imaging biomarker for pulmonary hemorrhage, which could play a pivotal role in improving clinical decision-making and management strategies for patients undergoing BPA.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Páez-Carpio A, Cornellas L, Domenech-Ximenos B, et al. Non-contrast dual-energy CT iodine quantification for lung injury characterization after balloon pulmonary angioplasty. Eur J Radiol. 2025. PMID: 40267560. doi:10.1016/j.ejrad.2025.112129

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。